obesity and glp 1 Optimizing GLP-1 therapies for diabetes management What is the pipeline for

Glutathione responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics

From delayed reimbursements to denial rates, practic

High cellular uptake and extremely low cytotoxicity are shown by GO Nano sheets, as they did some explorations on these suitable nanocarriers for intracellular fluorescent nanoprobe and drug delivery

After administration, eight of those men developed erections within an average time of 38 minutes

Patients assigned to tirzepatide showed a 20.9% BW loss after 36 weeks with an additional 5.5% reduction after 52 weeks, while those who switched to placebo experienced a 14% weight regain, confirming the findings from STEP 4 supporting the chronicity of obesity and the need for continuous treatment

Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials